Cleveland Jewish News: William Schiemann, associate professor of general medical sciences, led a team of researchers who found a link between a micro ribonucleic acid molecule and late-stage breast cancer. “Our micro RNA inactivates [a protein called] Bim, and we think this leads to chemo resistance to these metastatic cancers,” Schiemann said. Lower Bim levels, coupled with higher miR-181a levels, allow the spread of cancer.
Medicine’s William Schiemann and researchers target molecule’s role in late-stage breast cancer
- Law’s Michael Benza talks about questions surrounding not guilty verdict of Michael Brelo
- Medicine’s Krzysztof Palczewski discusses research on cells behind eyes
- Treating gum disease reduces prostate symptoms, CWRU researchers find
- Writing Resource Center to offer summer hours beginning June 1
- Give feedback on learning management systems at June 4 UCITE session